Background
==========

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play key roles in the regulation of immune responses to a variety of antigens and immune sentinels as initiators of T cell responses against microbial pathogens \[[@B1]-[@B3]\]. In addition, during inflammation or infection, DCs are mobilized in and out of the peripheral tissues. Activated DCs are targeted to secondary lymphoid organs and toward T cell activation by antigen presentation \[[@B4],[@B5]\]. DCs can capture degraded bacteria or protein of bacteria and present their antigens on major histocompatibility complex (MHC) class molecules to T cells \[[@B6]\]. As a result, an adaptive immune response that specifically targets bacteria-derived antigens is initiated. Maturing DCs then migrate to the lymphoid organs, where they activate naïve T cells by stimulating antigenic peptide-presenting MHC type I and II receptors and their co-stimulatory molecules \[[@B7]\]. Therefore, DCs provide a link between innate and adaptive immune responses.

*Salmonella*species cause typhoid fever and gastroenteritis in humans and pose a global threat to human health \[[@B8]\]. *Salmonella*also infect broad array of animals, resulting in diseases ranging from gastroenteritis to life-threatening systemic infections \[[@B9],[@B10]\]. A recent report has shown that *Salmonella enterica*serovar Typhimurium is a bacterial pathogen capable of interfering with DC functions, and causes a typhoid-like disease in mice \[[@B11]\]. It has also been reported that the effect of selectively reduced intracellular proliferation of *S. enteria*serovar Typhimurium within APCs limits both antigen presentation and development of a rapid CD8 T cell response \[[@B12]\]. Outer membrane protein (Omp) from *S. enteria*serovar Typhimurium was shown to contribute to confers protection against typhod.

However, it is still not known if hosts mount protective immune responses against *S. enterica*serovar Typhimurium, thus understanding how the immune system responds to these bacteria is essential for the development of an effective *S. enterica*serovar Typhimurium vaccine.

In this study, we determined the effects of a non-cytotoxic concentration of purified outer membrane protein A from *S. enterica*serovar Typhimurium (OmpA-sal) on the maturation and function of DCs. Our findings suggest, for the first time, that exposure to OmpA-sal induces phenotypic and functional maturation of DCs. Interestingly, exposure to OmpA-sal induced the activation of ERK1/2 and p38 MAPK via TLR4. The findings presented herein suggest that OmpA-sal induces activation of DCs and initiates an adaptive immune response by polarizing T-cell development to a Th1 response, information which will prove crucial in the development of a *S. enterica*serovar Typhimurium vaccine.

Results
=======

OmpA-sal induces DC maturation
------------------------------

We purified OmpA-sal from *E. coli*and assessed its cytotoxicity on DCs because the purified OmpA-sal was derived from *S. enterica*serovar Typhimurim. DCs were treated with various concentrations of OmpA-sal for 24 h. There were no statistically significant differences in the percentages of dead cells in DC cultures exposed to as much as 800 ng/ml of OmpA-sal, the concentration at which cell death was detected by annexin V/PI staining (Fig. [1A](#F1){ref-type="fig"}). This indicated that our recombinant OmpA-sal was not cytotoxic to DCs and did not contain amounts of endotoxin that would interfere with our studies using concentrations \< 400 ng/ml. To determine the effects of OmpA-sal on the maturation of sentinel DCs into effector DCs, BM-derived DCs were cultured with GM-CSF and IL-4 for 6 days under standard conditions, followed by 1 day in the presence of 100, 200, and 400 ng/ml of OmpA-sal. LPS was used as a positive control. The resulting populations of DCs were analyzed by flow cytometry for expression of co-stimulatory molecules involved in T cell activation. OmpA-sal-treated DCs had increased expression of DC maturation co-stimulatory markers (DC80, CD86, MHC class I, and MHC class II; Fig [1B](#F1){ref-type="fig"}). Interestingly, the expression of CD86 and MHC class II by OmpA-sal-treated DCs was higher than LPS-treated DCs. These results indicated that OmpA-sal induces DC maturation in a dose-dependent manner.

![**OmpA-sal is not cytotoxic and induces the expression of co-stimulatory molecules in DCs**. BM-DCs were cultured for 24 h in the presence of 200 ng/ml of LPS or 100, 200, 400, and 800 ng/ml of OmpA-sal and analyzed by flow cytometry. The DCs were stained with annexin V and PI. The percentage of positive cells is indicated (A). The cells were gated to exclude CD11c^+^cells. Medium, untreated control; LPS, positive control. DCs were stained with anti-CD80, anti-CD86, anti-MHC class I, and anti-MHC class II molecules (B). The data are representative of three experiments that yielded similar results.](1471-2180-10-263-1){#F1}

OmpA-sal reduces the endocytic activity of DCs
----------------------------------------------

Immature DCs are efficient in the capture and endocytosis of antigens. These cells can internalize large amounts of antigen through each fluid-phase uptake via macropinocytosis and receptor-mediated uptake. However, in the case of mature DCs, the capacity to capture antigen and confer potent co-stimulatory activity for T cells is decreased \[[@B13]\]. We investigated whether OmpA-sal-treated DCs had reduced endocytic activity characteristic of functionally mature DCs. As shown in Fig. [2A](#F2){ref-type="fig"}, the percentage of double-positive cells was lower in the LPS-treated DCs than in the untreated DCs. Similarly, the percentage of double-positive cells was lower in the OmpA-sal-treated DCs compared with untreated DCs. These data show that the OmpA-sal-treated DCs had reduced endocytic activity, which indicates functional maturity.

![**Treatment of OmpA-sal decreases endocytic capacities of DCs and induces production of IL-12**. On day 6, the cells were cultured at standard conditions for another 24 h in the presence of 200 ng/ml of LPS or 100, 200, and 400 ng/ml of OmpA-sal and harvested, and stained with a PE-conjugated anti-CD11c^+^antibody. Endocytic capacity at 37°C or 4°C was assessed by dextran-FITC uptake (A). The percentage of positive cells is indicated for each condition and is representative of the data of three separate experiments (B). Analysis of IL-12p70 and IL-10 cytokine production in magnetic bead-purified DCs by ELISA (C). The data are the means and standard deviation of three experiments. \*p \< 0.05, \*\*p \< 0.01 vs. untreated DCs.](1471-2180-10-263-2){#F2}

OmpA-sal increases the number of IL-12-producing DCs, but not IL-10
-------------------------------------------------------------------

APC, such as DCs, have been shown to direct Th1 development by production of IL-12 \[[@B14]\]. The effector factors that drive the development of Th1- and Th2-type T cells are IL-12 from DCs and IFN-γ or IL-4 from T cells. We determined whether OmpA-sal induced differentiation of Th1 subsets, and IL-12-producing DCs were analyzed by flow cytometry and ELISA. We also investigated the production of both intracellular IL-12p40p70 and bioactive IL-12p70 in OmpA-sal-treated DCs. As shown in Fig. [2B](#F2){ref-type="fig"}, OmpA-sal treatment of DCs increased the percentage of IL-12-producing cells compared with the results obtained for untreated DCs. Next, we investigated the production of IL-10, a pleoiotropic cytokine known to have inhibitory effects on the accessory functions of DCs, which appears to play a role in Th2 immune responses. The production of IL-10 was detectable similar to that of negative controls (Fig. [2C](#F2){ref-type="fig"}).

OmpA-sal-treated DCs enhances Th1 polarization and IFN-γ production
-------------------------------------------------------------------

To determine whether or not OmpA-sal-treated DCs stimulate CD4^+^T cell activation, we stimulated DCs with 400 ng/ml of OmpA-sal for 24h and performed an allogeneic mixed-lymphocyte reaction. CD4^+^splenic T cells from BALB/c mice were co-cultured with OmpA-sal-treated DCs derived from C57BL/6 mice. The OmpA-sal-treated DCs induced an advanced rate of T-cell proliferation compared to the untreated control DCs (Fig. [3A](#F3){ref-type="fig"}). In addition, we determined the cytokine production of CD4^+^T cells stimulated by OmpA-sal-treated DCs. As shown in Fig. [3B](#F3){ref-type="fig"}, allogeneic T cells primed with OmpA-sal-treated DCs produced a Th1 cytokine profile that included large amounts of IFN-γ and low amounts of IL-4. These data suggest that OmpA-sal enhances the immunostimulatory capacity of DCs to stimulated T cells. Moreover, we investigated whether cosignaling via CD80 and/or CD86 enhances Th1 response, we found that blockage of CD80 and CD86 decreased IFN-γ production. These data suggested that both CD80 and CD86 are essential for the Th1 response of OmpA-sal treated DCs.

![**OmpA-sal-treated DCs induces proliferation of allogenic T cells and enhanced Th1 resoponse *in vitro***. The DCs were incubated for 24 h in medium alone, in 200 ng/ml LPS, or in 400 ng/ml of OmpA-sal. The DC were washed and co-cultured with T cells. Cluster formation was assessed after 72 h. One representative experiment of three is also included in the figure, showing a representative field in a culture well photographed using an inverted phase contrast microscope and a mixed lymphocyte reaction was allowed to proceed for 3 days, T-cell proliferation was analyzed by flow cytometry and presented as a percentage of dividing cells (A). Cells were then examined for cytokine release after 48 h. IFN-γ and IL-4 were measured by ELISA in culture supernatants (B, C). Medium represents the chemically untreated control group. Similar results were obtained and expressed as the means (±SD) from four separate experiments. \*\*p \< 0.01 vs. untreated DCs.](1471-2180-10-263-3){#F3}

OmpA-sal induces DC maturation by TLR4 signaling
------------------------------------------------

Toll-like receptors (TLRs) link innate and adaptive immune responses \[[@B15]\]. The DC response to TLR ligands depends on the activation of mitogen-activated protein kinases (MAPKs), including ERK1/2, JNK1/2, and p38 MAPK \[[@B16]\]. We determined the effects of OmpA-sal on TLRs and the MAPK signaling pathway. DCs were treated with 400 ng/ml of OmpA-sal and TLR activation was measured by real-time quantitative reverse transcription-PCR and phophorylation-specific Western blotting. The level of TLR4 mRNA was significantly higher in OmpA-sal-treated DCs than in untreated control DCs, but there was no change in TLR2 mRNA (Fig. [4A](#F4){ref-type="fig"}). Moreover, OmpA-sal enhanced the phosphorylation of ERK1/2 and p38 MAPK in DCs, but not JNK1/2 (Fig. [4B](#F4){ref-type="fig"}). To confirm whether or not the maturation of DCs by OmpA-sal was mediated by a TLR4-related signaling pathway, we isolated DCs from TLR2 and TLR4 knock-out mice, then measured IL-12 production in DCs by OmpA-sal treatment. The inducing effect of OmpA-sal on IL-12 production was completely inhibited by TLR4^-/-^DCs, but it had no effect on TLR2^-/-^DCs (Fig. [4C](#F4){ref-type="fig"}). Moreover, we demonstrated that OmpA-sal-treated TLR4^-/-^DCs had no increased expression of DC maturation co-stimulatory markers (DC80, CD86, MHC class I, and MHC class II; Fig [4D](#F4){ref-type="fig"}). These results indicate that the activation and maturation of DCs by OmpA-sal is involved in TLR4 signaling.

![**OmpA-sal induces TLR4 expression, ERK activation, and p38 MAPK activation, but not JNK activation**. Total RNA was extracted, and quantitative real-time PCR was performed using sequence-specific primers for TLR2 and TLR4 (A).. Cell lysates were prepared and blotted with anti-phopho-p38, anti-p38, anti-phopho-ERK1/2, anti-ERK1/2, anti-phopho-JNK1/2, and anti-JNK1 antibody. A signal was detected with biotinylated goat-anti mouse IgG and visualized using enhanced chemiluminescence (B). DCs, TLR2^-/-^DCs, and TLR4^-/-^DCs were cultured for 24 h in the presence of 200 ng/ml of LPS or 400 ng/ml of OmpA-sal and the production levels of IL-12 analyzed by ELISA (C). BM-DCs and TLR4^-/-^DCs were cultured for 24 h in the presence of 400 ng/ml of OmpA-sal and surface markers analyzed by flow cytometry (D). The data are the means and standard deviation of three experiments. \*\*, P \< 0.01 for a compare with untreated DCs.](1471-2180-10-263-4){#F4}

Discussion
==========

We have shown that OmpA-sal, a major virulence factor of *S. enterica*serovar Typhimurium, is a highly immunogenic protein that induces Th1 polarization of T cells by DC maturation. Some of the Omps from bacteria induce DC maturation and regulate Th1/Th2 immune responses \[[@B17]-[@B19]\]. Isibasi et al previously investigated the Omp of *Salmonella*as potential vaccine candidates, diagnostic antigens, and virulence factors \[[@B20]\]. However, the molecular mechanisms of the involvement of DCs and T cells in the immune responses still unknown. The lack of understanding of protective immunity against *S. enterica*serovar Typhimurium has hindered the development of an efficacious vaccine. In this study, we found that OmpA-sal induces activation and maturation of DCs, as demonstrated by the high expression of co-stimulatory and MHC class molecules on cell surfaces and reduced endocytic activity. In addition, OmpA-sal-treated DCs induced primary T cell stimulatory activity in an allogeneic mixed lymphocyte reaction and elicited Th1 polarization through high levels of IFN-γ and low levels of IL-4. We have also shown in the current study that various concentrations of OmpA-sal induce high expression of CD80, CD86, MHC class I, and MHC class II in DCs. Moreover, OmpA-sal-treated DCs produced high levels of IL-12, but not IL-10. These data suggest that OmpA-sal strongly induces activation and maturation of DCs, and as a result DCs transmit OmpA-sal to the adaptive immune response. Successful induction of an adaptive immune response is characterized based on which antigen is presented, the dose, and the duration of presentation \[[@B21]-[@B23]\]. In the case of antigen recognition, an intracellular/extracelluar signaling cascade leads to activation of APCs, which in turn promotes further activation of DCs and activated T cells, and results in proliferation of T cells and their differentiation into effector T cells \[[@B5]\]. Accordingly, T cell proliferation in mixed lymphocyte reactions is important for efficient induction of an adaptive immune response by interaction between DCs and T cells. In the current study, we showed that OmpA-sal remarkably stimulates T cell proliferation and IFN-γ production, which is a key cytokine of Th1 polarization through the increase in IL-12 production by DCs. These findings indicate that OmpA-sal from *S. enterica*serovar Typhimurium can induce the Th1 immune response by DC maturation and IL-12 production.

We also provide evidence that OmpA-sal activates TLR signaling pathways in DCs. The recognition of antigen by TLRs leads to activation of MAPK pathways in DCs \[[@B24]\]. Therefore, the activation of MAPK by OmpA-sal is a possible mechanism underlying the increased expression of IL-12 by DCs. In this study, we found that OmpA-sal binds to a TLR4 on DCs and activates MAPK signaling pathway-mediated IL-12 production. DC produces IL-12 and direct activation of CD4-positive T cells to differentiate into Th1 cells that produce high levels of IFN-γ \[[@B25],[@B26]\]. We confirmed these results using TLR2^-/-^DCs and TLR4^-/-^DCs. OmpA-sal treated TLR2^-/-^DCs or TLR4^-/-^DCs and then analyzed IL-12 production by ELISA. We found that OmpA-sal-treated TLR4-/- DCs had no IL-12 production. These results suggest that OmpA-sal induced the maturation and activation of DCs via a TLR4-mediated signaling pathway.

Conclusions
===========

We demonstrated that OmpA-sal is a potent antigen and initiates a specific Th1 immune response *in vitro*. Further understanding of the mechanism by which OmpA-sal activates DC maturation and activation may facilitate the development of effective *S. enterica*serovar Typhimurim vaccines and an effective immunotherapeutic adjuvant for other infectious diseases.

Methods
=======

Animals
-------

Male 6-8 week old C57BL/6 (H-2K^b^and I-A^b^) and BALB/c (H-2K^d^and I-A^d^) mice were purchased from the Korean Institute of Chemistry Technology (Daejeon, Korea).

Reagents and Antibodies
-----------------------

Recombinant mouse (rm)GM-CSF and rmIL-4 were purchased from R&D Systems. Dextran-FITC and LPS (from *Escherichia coli*055:B5) were obtained from Sigma-Aldrich. An endotoxin filter (END-X) and an endotoxin removal resin (END-X B15) were acquired from Associates of Cape Cod. Cytokine ELISA kits for murine IL-12 p70, IL-4, IL-10, and IFN-γ were purchased from BD Pharmingen. FITC- or PE-conjugated monoclonal antibodies (mAbs; BD Pharmingen) were used for flow cytometry to detect CD11c (HL3), CD80 (16-10A1), CD86 (GL1), IA^b^β-chain (AF-120.1), H2K^b^(AF6-88.5), IL-12 p40/p70 (C15.6), and IL-10 (JESS-16E3). Anti-phospho-ERK1/2, anti-phospho-p38 MAPK, anti-phospho-JNK1/2, anti-ERK1/2, anti-JNK1, and anti-p38 MAPK mAb were purchased from Cell signaling. Isotype-matched control mAbs and biotinylated anti-CD11c (N418) mAb were purchased from BD Pharmingen.

Preparation of OmpA-sal
-----------------------

The full-length OmpA-sal gene (X02006.1) was amplified by PCR, and a chromosomal preparation of X02006.1 was used as a PCR substrate. The upstream primer, 5\'-GCGGATCCCACGA AGCCGGAGAA-3\', was designed to carry the EcoRI restriction site. The downstream primer, 5\'-GCAAGCTTAGAAACGATAGCC-3\', carried the HindIII restriction site. PCR products digested with EcoRI and HindIII were ligated into the pMAL™ expression vector (New England Biolabs Inc.). *E. coli*BL21 (DE3)/pMAL™ harboring a ompA-Sal gene was grown in Luria-Bertani (LB) medium at 37°C. Recombinant proteins were over-expressed by a bacteria protein expression system \[[@B27]\]. The quantity of OmpA endotoxin was ≤0.01 ng/mg.

Generation and culture of DCs
-----------------------------

DCs were generated from murine whole bone marrow (BM) cells. Briefly, the BM was flushed from the tibiae and femurs of BALB/c mice and depleted of red blood cells with ammonium chloride. The cells were plated in 6-well culture plates (10^6^cells/ml) and cultured at 37°C in 5% CO~2~and OptiMEM (Invitrogen Life Technologies) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 5 × 10^-5^M β-mercaptoethanol, 10 mM HEPES (pH 7.4), 20 ng/ml rmGM-CSF, and rmIL-4. On day 3 of culture, floating cells were gently removed and fresh medium was added. On day 6 or 7 of culture, non-adherent cells and loosely adherent proliferating DC aggregates were harvested for analysis or stimulation, or in some experiments, replated into 60 mm dishes.

Quantitation of antigen uptake
------------------------------

In brief, DCs were equilibrated at 37°C or 4°C for 45 min, then pulsed with fluorescein-conjugated dextran at a concentration of 1 mg/ml. Cold staining buffer was added to stop the reaction. The cells were washed three times and stained with PE-conjugated anti-CD11c Abs, then analyzed with the FACSCalibur. Non-specific binding of dextran to DCs was determined by incubation of DCs with FITC-conjugated dextran at 4°C and subtracted as background. The medium used in the cultures with OmpA-sal stimulation was supplemented with GM-CSF, which is required for the ability of DCs to capture antigen.

Cytokine assays
---------------

Cells were first blocked with 10% (v/v) normal goat serum for 15 min at 4°C, then stained with FITC-conjugated CD11c^+^antibody for 30 min at 4°C. Cells stained with the appropriate isotype-matched Ig were used as negative controls. The cells were fixed and permeabilized with the Cytofix/Cytoperm kit (PharMingen) according to the manufacturer\'s instructions. Intracellular IL-12p40/p70 and IL-10 were detected with fluorescein PE-conjugated antibodies (PharMingen) in a permeation buffer. The presence of murine IL-12p70, IL-10, IL-4, and IFN-γ in DCs was measured using an ELISA kit (R&D systems) according to the manufacturer\'s instructions.

Cytoplasmic extracts and Western blot
-------------------------------------

The cells were exposed to LPS (200 ng/ml) with or without OmpA-sal pre-treatment (400 ng/ml). Following 5, 10, 15, or 30 min of incubation at 37°C, cells were washed twice with cold PBS and lysed with modified RIPA buffer for 15 min at 4°C. The protein content of cell lysates was determined using the Micro BCA assay kit (Pierce, Rockford, IL, USA). Equivalent amounts of proteins were separated by 10% or 12% SDS-PAGE and analyzed by Western blotting using anti-phospho-ERK1/2, anti-phospho-p38 MAPK, anti-phospho-JNK1/2, anti-ERK1/2, anti-JNK1, and anti-p38 MAPK mAb for 3 h, as described by the manufacturers.

Mixed lymphocyte reaction
-------------------------

Responder T cells, which participate in allogeneic T-cell reactions, were isolated from spleens of BALB/c mice using a MACS column (positive selection sorting). Staining with FITC-conjugated anti-CD4 Abs revealed that the recovered cells consisted mainly of CD4^+^cells. The lymphocyte population was then washed twice in PBS and labeled with CFSE, as previously described \[[@B28]\]. The cells were washed once in pure FBS and twice in PBS with 10% FBS. DCs (1×10^4^), or DCs exposed to OmpA-sal or LPS for 24 h, were co-cultured with 1×10^5^allogeneic CFSE-labeled T lymphocytes in 96-well U-bottom plates. After 3 days, the CFSE dilution optically-gated lymphocytes were assessed.

Evaluation of gene expression by real time PCR
----------------------------------------------

TLR 2 and 4 PCR primers were used. Quantitative amounts of each gene were standardized against the GAPDH housekeeping gene. Real-time PCR was performed using a BioRad MiniOpticon System (BioRad Laboratories, Ltd.) with a SYBR green fluorophore. Reactions were performed in a total volume of 20 μl, including 10 μl of 2x SYBR Green PCR Master Mix, 1 μl of each primer at 10 ng, and 1 μl of the previously reverse-transcribed cDNA template. The protocols used were as follows: denaturation (95°C for 10 min), and amplification repeated 40 times (95°C for 30 s, 52°C for 30 s, 72°C for 30 s, and acquisition temperature for 15 s).

Statistical analysis
--------------------

All data are expressed as the mean ± standard deviation (SD) and were representative of at least two different experiments. Comparisons between individual data points were made using the Student\'s *t*-test and performed using one-way ANOVA analysis (Least Significant Difference (LSD) as post-hoc test). Throughout the figures and legends, the following terminology was used to denote statistical significance:\*\*, *p*\< 0.01, \*, *p*\< 0.05.
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